Literature DB >> 24713713

Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome.

Abdullah Sayied Abdullah1, Hatim Yagoub, Thomas J Kiernan, Caroline Daly.   

Abstract

Antiphospholipid syndrome (APS) is an autoimmune multisystem disorder characterised by high incidence of arterial and venous thrombosis. Cardiovascular manifestations also include valvular heart disease, ventricular thrombi and higher risk for coronary artery disease (CAD). In this case report, we describe a 61-year-old woman who had no significant risk factors for CAD, and presented with aggressive disease in native and graft vessels that required multiple coronary interventions. The extent of her aggressive CAD could not be explained by her risk factors profile. Therefore autoantibodies screening was carried out and showed a strongly positive anticardiolipin and β2 glycoprotein-I antibody, and hence a diagnosis of antiphospholipid syndrome was made.

Entities:  

Mesh:

Year:  2014        PMID: 24713713      PMCID: PMC3987570          DOI: 10.1136/bcr-2013-203499

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

2.  Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction.

Authors:  P Soltesz; H Der; K Veres; R Laczik; S Sipka; G Szegedi; P Szodoray
Journal:  Rheumatology (Oxford)       Date:  2008-09-09       Impact factor: 7.580

Review 3.  Current concepts on the pathogenesis of the antiphospholipid syndrome.

Authors:  Bill Giannakopoulos; Freda Passam; Soheila Rahgozar; Steven A Krilis
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

4.  beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program.

Authors:  R L Brey; R D Abbott; J D Curb; D S Sharp; G W Ross; C L Stallworth; S J Kittner
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

Review 5.  Valvular heart disease in antiphospholipid syndrome.

Authors:  Stéphane Zuily; Olivier Huttin; Shirine Mohamed; Pierre-Yves Marie; Christine Selton-Suty; Denis Wahl
Journal:  Curr Rheumatol Rep       Date:  2013-04       Impact factor: 4.592

6.  Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge.

Authors:  Irene Em Bultink
Journal:  Arthritis Res Ther       Date:  2010-02-22       Impact factor: 5.156

Review 7.  Inflammation in atherosclerosis: from pathophysiology to practice.

Authors:  Peter Libby; Paul M Ridker; Göran K Hansson
Journal:  J Am Coll Cardiol       Date:  2009-12-01       Impact factor: 24.094

8.  Newer antiphospholipid antibodies predict adverse outcomes in patients with acute coronary syndrome.

Authors:  Thomas P Greco; Ann Marie Conti-Kelly; Thomas Greco; Robin Doyle; Eiji Matsuura; J Robert Anthony; Luis R Lopez
Journal:  Am J Clin Pathol       Date:  2009-10       Impact factor: 2.493

Review 9.  Apoptosis and antiphospholipid antibodies.

Authors:  V Pittoni; D Isenberg
Journal:  Semin Arthritis Rheum       Date:  1998-12       Impact factor: 5.532

10.  Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.

Authors:  Johanna Gustafsson; Iva Gunnarsson; Ola Börjesson; Susanne Pettersson; Sonia Möller; Guo-Zhong Fei; Kerstin Elvin; Julia F Simard; Lars-Olof Hansson; Ingrid E Lundberg; Anders Larsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2009-12-10       Impact factor: 5.156

View more
  1 in total

1.  Primary antiphospholipid syndrome presenting as antiphospholipid syndrome nephropathy: a case report.

Authors:  Rajitha Asanga Abeysekera; Abdul Wahid Mohomad Wazil; Nishantha Nanayakkara; Neelakanthi V I Ratnatunga; Kaushal Maithree Fernando; Jalitha Thinnarachchi
Journal:  J Med Case Rep       Date:  2015-01-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.